We’ve spent two days scouring the internet looking for Plan B for what happens in the event of complete Covid-19 vaccine failure. So what does happen if the vaccines fail? Here is what we have found so far:
Actually, we found no results. It seems that no one is even asking the question. Perhaps it’s time to start that conversation?
UAE and Bahrain continue to inject Pfizer vaccine to boost immunity for those who have received two full doses of Sinopharm from China.
These two Gulf countries have vaccinated the majority of the population with Covid-19, mainly with a vaccine manufactured by China National Pharmaceutical Corporation (Sinopharm).
The United Arab Emirates (UAE) has administered more than 13 million doses of the vaccine to a population of more than 9.7 million, while Bahrain has injected at least 1.7 million doses, or 54.1% of the population.
However, Bahrain is now fighting the biggest wave of infections since the beginning of the pandemic, while the UAE is recording almost twice as many nCoV infections as it did seven months ago.
This fact forced the two countries to decide to give Pfizer/BioNTech vaccine as a “booster dose” for those who have had two full doses of Sinopharm.
VNExpress.net report (in Vietnamese)
As of Sunday 30th May 2021, Guangdong had recorded a total of 2,468 cases with 1,035 of them imported. Currently, 75 people are in hospital. Guangdong province has also identified two imported confirmed cases, one from Cambodia to Guangzhou, and another from the United States to Foshan. Guangzhou has reported eight asymptomatic imported cases – from the United Arab Emirates, US, Chad, Amman, the Philippines, Cambodia and Papua New Guinea.
Parts of southern China are in lockdown to contain the Covid-19 outbreak. Guangzhou bears the brunt of latest cluster with 38 zones sealed to stop the spread as new infections continue to be identified.
Researchers reported that among 20 fully-vaccinated healthcare workers with vaccine breakthrough COVID-19 cases, all were infected with coronavirus variants. An earlier study had linked breakthrough infections with low viral loads, suggesting low transmission risks, but “we found many samples in our breakthrough cohort with high viral load,” said coauthor Pavitra Roychoudhury of the University of Washington. CONTAGIOUS: “Our work suggests that not all breakthrough infections are at low risk of initiating transmission and, if they did, these infections could lead to the continued spread of variants of concern, particularly in areas with low vaccination rates.”
The CDC has genetic data for virus samples from 555 vaccine breakthrough infections. Mutated variants of the coronavirus, including those first seen in the UK and South Africa, accounted for 64% of the breakthroughs.
Medrxix preprint – Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State
FT: “the vaccines send the DNA gene sequences of the spike protein into the cell … Once inside the cell nucleus, certain parts of the spike protein splice, or split apart“
During the last months many countries have started the immunization of millions of people by using vector-based vaccines. Unfortunately, severe side effects became overt during these vaccination campaigns: cerebral venous sinus thromboses (CVST), absolutely rare under normal life conditions, were found as a severe side effect that occured 4-14 days after first vaccinations. Besides CVST, Splanchnic Vein Thrombosis (SVT) was also observed. This type of adverse event has not been observed in the clinical studies of AstraZeneca, and therefore led immediately to a halt in vaccinations in several european countries.
These events were mostly associated with thrombocytopenia, and thus, similar to the well-known Heparin-induced thrombocytopenia (HIT). Meanwhile, scientists have proposed a mechanism to explain this vaccine-induced thrombocytopenia. However, they do not provide a satisfactory explanation for the late thromboembolic events. Here, we present data that may explain these severe side effects which have been attributed to adenoviral vaccines.
According to our results, transcription of wildtype and codon-optimized Spike open reading frames enables alternative splice events that lead to C-terminal truncated, soluble Spike protein variants. These soluble Spike variants may initiate severe side effects when binding to ACE2-expressing endothelial cells in blood vessels. In analogy to the thromboembolic events caused by Spike protein encoded by the SARS-CoV-2 virus, we termed the underlying disease mechanism the “Vaccine-Induced Covid-19 Mimicry” syndrome (VIC19M syndrome).
Researchgate paper “Vaccine-Induced Covid-19 Mimicry Syndrome: Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines”.
FT Article “Scientists claim to have solved Covid vaccine blood-clot puzzle”
Bahrain, a country of just 1.7 million people, recorded 3,177 new COVID-19 infections and 11 deaths on Sunday 23rd May 2021. The country has now had to more than 218,000 coronavirus cases with over 800 deaths. Earlier this month authorities said they would expand the country’s vaccination campaign to include adolescents aged 12-17. There seems to be two main variants in Bahrain – B.1.351 and B.1.617.2 – which account for nearly half of all infections
Bahrain offers citizens and residents four vaccines free of charge: the Pfizer/BioNTech vaccine, China’s Sinopharm, the AstraZeneca vaccine and Russia’s Sputnik V. The Johnson & Johnson’s vaccine has also been approved for emergency use.
The highest ever daily country case figure for coronavirus on Planet Earth was recorded in The Seychelles in May 2021. The Seychelles daily case figure, adjusted for population, reached an astonishing 4,083 cases per million.
What is also surprising is that many of the countries on the list with the highest daily case rates also have excellent vaccination rates (see below). The Seychelles, for example, has vaccinated more than 60% of its population.
The reasons behind some of the high daily case numbers are given in articles we have previously published and have linked to below.
Covid-19 cases in The Seychelles, where 57% of the population have been fully inoculated with Sinopharm shots, increased to 2,486 people – 37 per cent of whom have had two doses of the vaccine.
Sinopharm vaccine shots were issued to 57 per cent of those who were fully inoculated and the rest with Covishield, a vaccine made in India under a licence from AstraZeneca Plc. As of May 8th no one who had contracted Covid-19 while being vaccinated had died